Evaluation of the post-transfusion platelet increment and safety of riboflavin-based pathogen reduction technology (PRT) treated platelet products stored in platelet additive solution for 5 days or less versus 6-7 days.

@article{Kaplan2016EvaluationOT,
  title={Evaluation of the post-transfusion platelet increment and safety of riboflavin-based pathogen reduction technology (PRT) treated platelet products stored in platelet additive solution for 5 days or less versus 6-7 days.},
  author={Alesia Kaplan and Bruce R. Lindgren and Susanne Marschner and Mariv{\'i} Aznar and Saioa Zalba and Piva S{\'a}nchez and Mar{\'i}a Luisa Ayape and Eduardo Olavarr{\'i}a and Mar{\'i}a Luisa Antelo},
  journal={Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis},
  year={2016},
  volume={54 2},
  pages={248-52}
}
BACKGROUND AND OBJECTIVES Platelets are stored routinely for 5 days or less and extended platelet storage time could improve product availability. This study compared platelet count increments (CI24hs) of riboflavin plus UV-light (PRT) treated platelet products in platelet additive solution stored for 5 days or less to products stored for 6-7 days. MATERIAL AND METHODS This was a retrospective study comparing CI24hs between two groups. Hematology patients received PRT treated platelet… CONTINUE READING
2 Citations
39 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 39 references

Clinical evaluation of platelets treated with riboflavin and UV light in the presence of platelet additive solution in thrombocytopenic patients

  • M Yañez, A Garcia de Coca, L Medina, F Galvez, M Martin Vaca, M Martinez Alvarez
  • Vox Sang 2011;101:148
  • 2011
Highly Influential
12 Excerpts

A comparison of adverse reaction rates for PAS C versus plasma platelet units

  • SM Picker, ME Tauszig, BS Gathof
  • Transfusion
  • 2014

Four - year hemovigilance survey of mirasol - treated blood components in the Warsaw region

  • CS Cohn, J Stubbs, J Schwartz, R Francis, C Goss, M Cushing
  • Transfusion
  • 2014

Four-year hemovigilance survey of mirasoltreated blood components in the Warsaw region. Transfusion 2014;54:98A

  • M Letowska, Z Przybylska-Baluta, D Piotrowski, L Rzymkiewicz, E Lachert, M. Cardoso
  • 2014

Similar Papers

Loading similar papers…